WithdrawnPhase 3

Effect of Avastin in Juxtafoveal Telangiectasias

Stopped: Undefined

Mexico0Started 2006-09

Plain-language summary

Evaluation of efficacy of Intravitreal Injection of Bevacizumab in patients with Yuxtafoveal Telangiectasias

Who can participate

Age range40 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with Telangiectasias secondary to Branch Retinal Vein Occlusion * Patients with Idiopathic Juxtafoveal Retinal Telangiectasias Exclusion Criteria: * Diabetic Retinopathy and Diabetic Macular Edema * Hypertensive Retinopathy * Choroidal Neovascularization

What they're measuring

Best corrected Visual Acuity

Fluorescein Angiogram: Leakage

Optical Coherence Tomography: Retinal thickness

Trial details

NCT IDNCT00406380

SponsorAsociación para Evitar la Ceguera en México

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2006-09

View on ClinicalTrials.gov More Telangiectasis trials